Perseus-Soros Biopharmaceutical Fund

investment firm

Investments

Number of Investments
Number of Lead Investments
22
5
Perseus-Soros Biopharmaceutical Fund has made 22 investments. Their most recent investment was on Oct 30, 2009, when Xanodyne, Inc raised
Date Company Name Round Money Raised Industry Lead Investor
Oct 30, 2009 Xanodyne Series Unknown — Biotechnology —
Sep 29, 2008 CeNeRx BioPharma Series B — Biopharma —
Nov 14, 2007 Ambit Biosciences Series D — Biopharma —
May 1, 2006 Cardiokine Series B — Biotechnology —
Apr 12, 2006 SkinMedica Series E — Biotechnology —
Nov 14, 2005 CeNeRx BioPharma Series A — Biopharma —
May 12, 2005 Ambit Biosciences Series C — Biopharma —
Apr 6, 2005 SkinMedica Series E — Biotechnology —
Mar 2, 2005 ArgiNOx Phamaceuticals Series C — Biotechnology —
Aug 5, 2004 Just Kratom Store Series C — Health Care Yes
Jul 14, 2004 SkinMedica Series D — Biotechnology Yes
Jun 12, 2004 ArgiNOx Phamaceuticals Series B — Biotechnology —
Apr 13, 2004 Cardiokine Series A — Biotechnology Yes
Nov 7, 2003 Auxilium Pharmaceuticals Series D — Biotechnology —
Aug 29, 2003 Myogen Series D — Biopharma —
Jan 10, 2003 Aton Pharma Private Equity(PE) — Biotechnology —
Oct 22, 2002 Oculex Pharmaceuticals Series B — Biotechnology Yes
May 9, 2002 Advion Inc. Series B — Biotechnology Yes
Jan 3, 2002 Myogen Series D — Biopharma —
Oct 17, 2001 GeneFormatics Series Unknown — Biotechnology —
Oct 9, 2001 Aderis Pharmaceuticals Series D — Biopharma —
Dec 31, 2000 Ambit Biosciences Series B — Biopharma —